Nicotinic acetylcholine receptor (nAChR) α7 receptor neurons are important in the neurobiology of Alzheimer's disease, Parkinson's disease, and schizophrenia. This page provides detailed information about their structure, function, and role in disease processes.
Nicotinic Acetylcholine Alpha-7 Receptor Neurons express the nAChR α7 receptor, a ligand-gated ion channel that plays crucial roles in:
The α7 nAChR is widely expressed in the hippocampus, cortex, and basal forebrain. In Alzheimer's disease, α7 receptor density is reduced, contributing to cognitive deficits. This receptor is a therapeutic target for cholinergic therapies including donepezil and galantamine.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000197 | sensory receptor cell |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000197 | sensory receptor cell | Medium |
| Cell Ontology | CL:0004117 | retinal ganglion cell A | Medium |
| Property | Value |
|---|---|
| Receptor Type | nAChR α7 |
| Family | Nicotinic acetylcholine |
| Signaling Mechanism | Ligand-gated ion channel, rapidly desensitizing Ca2+ channel |
| Primary Location | Hippocampus, cortex, basal forebrain, hypothalamus |
Nicotinic Acetylcholine Alpha-7 Receptor Neurons are involved in Cognitive enhancement, attention, memory formation. These neurons express the nAChR α7 receptor which ligand-gated ion channel, rapidly desensitizing ca2+ channel. The receptor's location in hippocampus, cortex, basal forebrain, hypothalamus allows it to modulate neurotransmission and cellular signaling in key brain regions.
The nAChR α7 receptor signals through ligand-gated ion channel, rapidly desensitizing ca2+ channel. This mechanism allows rapid or modulatory responses depending on the cellular context and co-expression of other receptors.
Alzheimer's disease target, schizophrenia cognitive deficits. Understanding the role of these receptor neurons provides insight into potential therapeutic targets for these conditions.
The nAChR α7 receptor is a target for drug development in:
Neurological disorders
Neuropsychiatric conditions
Neurodegenerative diseases
Receptor Neurons
Neurotransmitter Systemsmechanisms/cholinergic-hypothesis-ad)
Nicotinic acetylcholine Signaling
The study of Nicotinic Acetylcholine Alpha 7 Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.